Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Meyer

Showing results (371-380 of 476) with videos related to

Pageof 48
Sort By:
American Journal of Human Genetics|April 28, 2006
Breakpoint cloning and haplotype analysis indicate a single origin of the common Inv(10)(p11.2q21.2) mutation among northern EuropeansMette Gilling, Jörn S Dullinger, Stefan Gesk, et al.
JAMA Neurology|December 2, 2014
Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment responseFrank Leypoldt, Romana Höftberger, Maarten J Titulaer, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|July 12, 2002
A novel treatment approach for low grade lymphoproliferative disorders using PKC412 (CGP41251), an inhibitor of protein kinase CAndres Virchis, Kanagasabai Ganeshaguru, Steve Hart, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|July 27, 2007
Guidelines for the preclinical in vivo evaluation of pharmacological active drugs for ALS/MND: report on the 142nd ENMC international workshopAlbert C Ludolph, Caterina Bendotti, Eran Blaugrund, et al.
JAMA|May 6, 2015
Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trialDale N Gerding, Thomas Meyer, Christine Lee, et al.
Journal of Psychosomatic Research|August 5, 2019
Longitudinal relationship between B-type natriuretic peptide and anxiety in coronary heart disease patients with depressionStella V Fangauf, Thomas Meyer, Christian Albus, et al.
Cancer Research|July 17, 2004
AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activityPeter Traxler, Peter R Allegrini, Ralf Brandt, et al.
Journal of Neurology|April 14, 2009
Identification of novel Angiogenin (ANG) gene missense variants in German patients with amyotrophic lateral sclerosisRubén Fernández-Santiago, Sabine Hoenig, Peter Lichtner, et al.
Communications Medicine|July 25, 2024
Tofersen decreases neurofilament levels supporting the pathogenesis of the SOD1 p.D91A variant in amyotrophic lateral sclerosis patientsJochen H Weishaupt, Péter Körtvélyessy, Peggy Schumann, et al.
Frontiers in Immunology|February 4, 2026
Machine learning-based prediction of one-year mortality after alloHCT identifies the impact of pre-transplant immunity and inflammationThomas Meyer, Robert Meyer, Maren Hackenberg, et al.
Pageof 48

Showing results (371-380 of 476) with videos related to

Sort By:
Pageof 48
American Journal of Human Genetics|April 28, 2006
Breakpoint cloning and haplotype analysis indicate a single origin of the common Inv(10)(p11.2q21.2) mutation among northern EuropeansMette Gilling, Jörn S Dullinger, Stefan Gesk, et al.
JAMA Neurology|December 2, 2014
Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment responseFrank Leypoldt, Romana Höftberger, Maarten J Titulaer, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|July 12, 2002
A novel treatment approach for low grade lymphoproliferative disorders using PKC412 (CGP41251), an inhibitor of protein kinase CAndres Virchis, Kanagasabai Ganeshaguru, Steve Hart, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|July 27, 2007
Guidelines for the preclinical in vivo evaluation of pharmacological active drugs for ALS/MND: report on the 142nd ENMC international workshopAlbert C Ludolph, Caterina Bendotti, Eran Blaugrund, et al.
JAMA|May 6, 2015
Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trialDale N Gerding, Thomas Meyer, Christine Lee, et al.
Journal of Psychosomatic Research|August 5, 2019
Longitudinal relationship between B-type natriuretic peptide and anxiety in coronary heart disease patients with depressionStella V Fangauf, Thomas Meyer, Christian Albus, et al.
Cancer Research|July 17, 2004
AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activityPeter Traxler, Peter R Allegrini, Ralf Brandt, et al.
Journal of Neurology|April 14, 2009
Identification of novel Angiogenin (ANG) gene missense variants in German patients with amyotrophic lateral sclerosisRubén Fernández-Santiago, Sabine Hoenig, Peter Lichtner, et al.
Communications Medicine|July 25, 2024
Tofersen decreases neurofilament levels supporting the pathogenesis of the SOD1 p.D91A variant in amyotrophic lateral sclerosis patientsJochen H Weishaupt, Péter Körtvélyessy, Peggy Schumann, et al.
Frontiers in Immunology|February 4, 2026
Machine learning-based prediction of one-year mortality after alloHCT identifies the impact of pre-transplant immunity and inflammationThomas Meyer, Robert Meyer, Maren Hackenberg, et al.
Pageof 48